Mission Statement, Vision, & Core Values of Inogen, Inc. (INGN)

Mission Statement, Vision, & Core Values of Inogen, Inc. (INGN)

US | Healthcare | Medical - Devices | NASDAQ

Inogen, Inc. (INGN) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

How does a company dedicated to improving lives define its purpose and values? For Inogen, Inc. (INGN), a leading global medical technology company focused on innovative respiratory products, the answers lie in its mission statement, vision, and core values. But what exactly are they, and how do they drive the company's operations and strategic decisions in the competitive healthcare market, where it closed the year with revenues of $328.3 million in 2024?

Understanding these guiding principles can offer valuable insights into the company's goals and how it aims to achieve them, especially as it navigates the complexities of the medical technology landscape. Are you curious to explore the mission, vision, and core values that shape Inogen's path forward?

Inogen, Inc. (INGN) An Overview of

Founded in 2001 and headquartered in Goleta, California, Inogen, Inc. is a global medical technology company that primarily focuses on developing, manufacturing, and marketing innovative respiratory products for use in the home. Their main product is the portable oxygen concentrator (POC), which provides supplemental long-term oxygen therapy (LTOT) to patients suffering from chronic respiratory conditions. These POCs are designed to offer greater freedom and mobility compared to traditional oxygen therapy systems. As of April 2025, Inogen continues to serve a significant market, providing solutions aimed at improving the quality of life for oxygen therapy patients.

Inogen’s financial performance reflects its position in the respiratory care market. In the most recent reporting period, Inogen announced a revenue of $91.3 million, a 14.4% increase compared to the previous quarter. This growth was largely driven by a significant increase in rental revenue, which surged by $5.2 million, representing a 23.8% rise quarter-over-quarter. However, the company reported a net loss of $1.9 million, or $0.08 per share, although this was an improvement compared to the net loss of $11.1 million, or $0.47 per share, in the prior year. Direct-to-consumer sales also saw a notable increase, climbing to $34.4 million, up 10.5% from the previous quarter, while domestic business-to-business sales rose to $11.9 million, marking a 10.2% increase. International business-to-business sales, however, experienced a decrease, falling to $8.4 million, down 13.5% quarter-over-quarter.

Inogen stands as one of the leading companies in the respiratory device industry, particularly known for its innovative portable oxygen concentrators. These devices have transformed the lives of many patients by offering a more convenient and mobile alternative to traditional oxygen therapy. The company's success can be attributed to several factors, including its focus on patient needs, technological innovation, and strategic market positioning. To delve deeper into the specifics of Inogen's journey, explore this resource: Inogen, Inc. (INGN): History, Ownership, Mission, How It Works & Makes Money.

Inogen, Inc. (INGN) Mission Statement

Inogen, Inc. (INGN) is dedicated to improving the lives and increasing the freedom and independence of oxygen therapy users. The company strives to achieve this through innovative products and services. Inogen's mission is rooted in the belief that oxygen therapy technology should keep pace with the lifestyles of patients who depend on it, enabling them to live longer and more fulfilling lives.

Inogen's commitment extends to developing, manufacturing, and marketing respiratory therapy devices that deliver care to patients suffering from chronic respiratory conditions. By partnering with patients, prescribers, home medical equipment providers, and distributors, Inogen ensures its products are widely accessible, empowering patients to manage their disease's impact and reclaim their mobility.

Inogen's purpose of improving lives through respiratory care is supported by its vision to be a global market leader with innovative, evidence-based chronic respiratory care solutions.

Core components of Inogen's mission statement include:

  • Patient-Centric Innovation: Focusing on creating solutions that address the unmet needs of oxygen therapy patients.
  • Quality and Reliability: Ensuring products meet the highest standards of performance and durability.
  • Accessibility and Independence: Making oxygen therapy more convenient and less restrictive for users.

Inogen's innovative approach is evident in its development of compact, lightweight, and travel-ready portable oxygen concentrators, which provide an alternative to heavy tanks and stationary systems. The company estimates that over 2.5 million patients in the United States and over 4.5 million patients worldwide use oxygen therapy.

Inogen's dedication to research and development ensures they remain at the forefront of respiratory therapy treatments, driving the adoption of portable oxygen concentrators to benefit a larger patient population. The company has sold or rented over one million systems worldwide since its inception.

Inogen aspires to live by the following values each day:

  • Self-Responsibility
  • Open Communication
  • Continuous Improvement
  • Integrity
  • Service

To learn more about Inogen's financial health, read this comprehensive analysis: Breaking Down Inogen, Inc. (INGN) Financial Health: Key Insights for Investors

Inogen, Inc. (INGN) Vision Statement of

To fully understand the strategic direction, it's important to examine the mission, vision, and core values. These elements provide a clear picture of its goals, guiding principles, and operational philosophy. For a deeper dive into the company's background and mission, you can check out Inogen, Inc. (INGN): History, Ownership, Mission, How It Works & Makes Money.

Mission Statement

To improve freedom and independence for oxygen therapy users through innovative products and services.

Vision Statement

A world of breath, when and where you want it.

Core Values

Inogen has five core values:

  • Integrity
  • Customer Focus
  • Innovation
  • Excellence
  • Teamwork
Analysis of the Vision Statement

The vision statement, 'A world of breath, when and where you want it,' is concise yet powerful. It encapsulates the company's aspiration to revolutionize the lives of oxygen therapy users. Here's a breakdown of the key components:

'A World of Breath'

This part of the vision statement evokes a sense of normalcy and ease for individuals who rely on oxygen therapy. It suggests a future where breathing is no longer a constraint, but rather a natural and effortless experience. This aligns with the company's commitment to providing solutions that enhance the quality of life for its users.

In 2024, the healthcare sector continued to emphasize patient-centric care, with a growing focus on improving the overall well-being and daily experiences of individuals with respiratory conditions.

'When and Where You Want It'

This phrase highlights the freedom and independence that company aims to provide. It implies that oxygen therapy should not limit a person's mobility or lifestyle. Instead, it should be accessible and convenient, allowing users to live their lives on their own terms.

As of the fiscal year 2024, technological advancements in portable oxygen concentrators (POCs) have significantly contributed to realizing this vision, offering smaller, lighter, and more efficient devices. The global portable oxygen concentrators market was valued at $2.8 billion in 2024 and is projected to reach $4.9 billion by 2032, growing at a CAGR of 7.3% from 2024 to 2032.

Alignment with Core Values

The vision statement is closely aligned with core values:

  • Innovation: The company seeks to create innovative products that enable the vision of breath, when and where you want it.
  • Customer Focus: By focusing on the needs of oxygen therapy users, the company ensures that its products and services directly address their challenges and improve their lives.
  • Excellence: Striving for excellence in product development and service delivery is essential to realizing the vision of providing seamless and reliable oxygen solutions.

In 2024, the company's dedication to these values was evident in its continued investment in research and development, as well as its commitment to providing exceptional customer support.

Inogen, Inc. (INGN) Core Values of

While specific, publicly available details on Inogen's core values are limited, we can infer key values from their mission, vision, and actions. These inferred values include innovation, patient-focus, integrity, quality, and teamwork. You can learn more about Inogen's mission and history here: Inogen, Inc. (INGN): History, Ownership, Mission, How It Works & Makes Money.

Innovation

Innovation appears to be a central value, given Inogen's focus on developing and marketing portable oxygen concentrators (POCs). This commitment is evident in their ongoing efforts to improve their products and expand their technological capabilities. In 2024, Inogen continued to invest in research and development, allocating $11.7 million, compared to $12.2 million in 2023, to enhance their product offerings and explore new technologies in respiratory care.

Patient-Focus

A patient-centric approach is likely a core value, as Inogen aims to improve the lives of individuals with respiratory conditions. This is reflected in their efforts to provide convenient and reliable oxygen therapy solutions that allow patients to maintain active and independent lifestyles. For example, Inogen's 2024 operating expenses included significant investments in sales and marketing to reach and support patients, with sales and marketing expenses totaling $71.8 million, compared to $73.8 million in 2023.

Integrity

Integrity is crucial for building trust with patients, healthcare providers, and investors. Inogen's commitment to ethical business practices and regulatory compliance underscores this value. In 2024, Inogen's general and administrative expenses, which include compliance and legal costs, were $37.6 million, reflecting their ongoing efforts to maintain high standards of integrity in their operations.

Quality

Maintaining high standards for product quality and reliability is essential in the medical device industry. Inogen's focus on delivering durable and effective POCs demonstrates their commitment to quality. This focus on quality is reflected in their manufacturing costs and quality control processes. In 2024, the cost of goods sold was $120.8 million, indicating significant investment in producing high-quality products.

Teamwork

Collaboration and teamwork are essential for driving innovation and achieving organizational goals. While explicit details on teamwork initiatives are not publicly available, it can be inferred that Inogen fosters a collaborative environment to develop and deliver their products. Their ability to innovate and expand their product line suggests effective teamwork across various departments, including research and development, manufacturing, and sales and marketing.

DCF model

Inogen, Inc. (INGN) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.